Andrea Alonso-Trisan
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Exhaled Volatile Organic Compounds as Potential Biomarkers of Exacerbation Risk in Asthma.
Journal: Archivos de bronconeumologia
Published: November 03, 2025
Early Failure, Late Failure, and Sustained Response to Biologics in Severe Asthma: A Long-term, Real-world, Multicentre study.
Journal: Archivos de bronconeumologia
Published: October 31, 2024
Concomitant Efficacy of Dupilumab in Treating Eosinophilic Esophagitis and Type 2 Asthma.
Journal: Journal of investigational allergology & clinical immunology
Published: May 10, 2024
Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial.
Journal: Bone marrow transplantation
Published: July 14, 2023
Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study.
Journal: Respiratory research
Published: July 10, 2023
Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population.
Journal: Archivos de bronconeumologia
Published: May 20, 2023
Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach.
Journal: Frontiers in allergy
Published: December 09, 2022
Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach.
Journal: Frontiers in allergy
Published: July 30, 2022
Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study.
Journal: Respiratory medicine
Published: January 09, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026